Integer Holdings Co. (NYSE:ITGR) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Integer Holdings Co. (NYSE:ITGR) have received an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $148.56.

A number of equities analysts have recently commented on the company. Benchmark boosted their target price on Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Friday, February 21st. KeyCorp boosted their price objective on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Oppenheimer cut shares of Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Finally, Raymond James began coverage on shares of Integer in a report on Friday, March 28th. They set an “outperform” rating and a $145.00 price target on the stock.

Institutional Trading of Integer

A number of large investors have recently modified their holdings of ITGR. Raymond James Financial Inc. bought a new position in Integer during the 4th quarter worth about $38,073,000. Capital Research Global Investors boosted its stake in shares of Integer by 16.0% during the fourth quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider’s stock valued at $186,960,000 after purchasing an additional 194,895 shares in the last quarter. Artisan Partners Limited Partnership purchased a new position in Integer during the fourth quarter valued at approximately $22,775,000. GAMMA Investing LLC raised its stake in Integer by 8,697.6% in the first quarter. GAMMA Investing LLC now owns 78,123 shares of the medical equipment provider’s stock worth $92,190,000 after buying an additional 77,235 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Integer during the 4th quarter valued at $7,889,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Price Performance

ITGR stock opened at $113.84 on Friday. The company has a fifty day simple moving average of $124.34 and a two-hundred day simple moving average of $131.00. Integer has a 52 week low of $104.93 and a 52 week high of $146.36. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $3.83 billion, a P/E ratio of 33.88, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The business had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. Analysts anticipate that Integer will post 6.01 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.